Table of Contents

July 1995; 44 (7)

Select this article
- J E Tooke
Microvascular function in human diabetes. A physiological perspective.
Diabetes July 1995 44:721-726; doi:10.2337/diabetes.44.7.721
- Abstract
Select this article
- B C Ko,
- K S Lam,
- N M Wat,
- and S S Chung
An (A-C)n dinucleotide repeat polymorphic marker at the 5' end of the aldose reductase gene is associated with early-onset diabetic retinopathy in NIDDM patients.
Diabetes July 1995 44:727-732; doi:10.2337/diabetes.44.7.727
- Abstract
Select this article
- H Kaneto,
- J Fujii,
- H G Seo,
- K Suzuki,
- T Matsuoka,
- M Nakamura,
- H Tatsumi,
- Y Yamasaki,
- T Kamada,
- and N Taniguchi
Apoptotic cell death triggered by nitric oxide in pancreatic beta-cells.
Diabetes July 1995 44:733-738; doi:10.2337/diabetes.44.7.733
- Abstract
Select this article
- P Rossing,
- K Rossing,
- P Jacobsen,
- and H H Parving
Unchanged incidence of diabetic nephropathy in IDDM patients.
Diabetes July 1995 44:739-743; doi:10.2337/diabetes.44.7.739
- Abstract
Select this article
- N Yagi,
- K Yokono,
- K Amano,
- M Nagata,
- K Tsukamoto,
- Y Hasegawa,
- R Yoneda,
- N Okamoto,
- H Moriyama,
- and M Miki
Expression of intercellular adhesion molecule 1 on pancreatic beta-cells accelerates beta-cell destruction by cytotoxic T-cells in murine autoimmune diabetes.
Diabetes July 1995 44:744-752; doi:10.2337/diabetes.44.7.744
- Abstract
Select this article
- A E Karlsen,
- H U Andersen,
- H Vissing,
- P M Larsen,
- S J Fey,
- B G Cuartero,
- O D Madsen,
- J S Petersen,
- S B Mortensen,
- and T Mandrup-Poulsen
Cloning and expression of cytokine-inducible nitric oxide synthase cDNA from rat islets of Langerhans.
Diabetes July 1995 44:753-758; doi:10.2337/diabetes.44.7.753
- Abstract
Select this article
- R D Hurst,
- Z S Stevanovic,
- S Munk,
- B Derylo,
- X Zhou,
- J Meer,
- M Silverberg,
- and C I Whiteside
Glomerular mesangial cell altered contractility in high glucose is Ca2+ independent.
Diabetes July 1995 44:759-766; doi:10.2337/diabetes.44.7.759
- Abstract
Select this article
- J Gromada,
- S Dissing,
- K Bokvist,
- E Renström,
- J Frøkjaer-Jensen,
- B S Wulff,
- and P Rorsman
Glucagon-like peptide I increases cytoplasmic calcium in insulin-secreting beta TC3-cells by enhancement of intracellular calcium mobilization.
Diabetes July 1995 44:767-774; doi:10.2337/diabetes.44.7.767
- Abstract
Select this article
- J C Krakauer,
- M J McKenna,
- N F Buderer,
- D S Rao,
- F W Whitehouse,
- and A M Parfitt
Bone loss and bone turnover in diabetes.
Diabetes July 1995 44:775-782; doi:10.2337/diabetes.44.7.775
- Abstract
Select this article
- F S Nielsen,
- P Rossing,
- L E Bang,
- T L Svendsen,
- M A Gall,
- U M Smidt,
- and H H Parving
On the mechanisms of blunted nocturnal decline in arterial blood pressure in NIDDM patients with diabetic nephropathy.
Diabetes July 1995 44:783-789; doi:10.2337/diabetes.44.7.783
- Abstract
Select this article
- G E Umpierrez,
- M M Casals,
- S P Gebhart,
- P S Mixon,
- W S Clark,
- and L S Phillips
Diabetic ketoacidosis in obese African-Americans.
Diabetes July 1995 44:790-795; doi:10.2337/diabetes.44.7.790
- Abstract
Select this article
- R Klein,
- B E Klein,
- and S E Moss
The Wisconsin Epidemiologic Study of Diabetic Retinopathy. XVI. The relationship of C-peptide to the incidence and progression of diabetic retinopathy.
Diabetes July 1995 44:796-801; doi:10.2337/diabetes.44.7.796
- Abstract
Select this article
- P L Rothenberg,
- L D Willison,
- J Simon,
- and B A Wolf
Glucose-induced insulin receptor tyrosine phosphorylation in insulin-secreting beta-cells.
Diabetes July 1995 44:802-809; doi:10.2337/diabetes.44.7.802
- Abstract
Select this article
- B S Szwergold,
- S Lal,
- A H Taylor,
- F Kappler,
- B Su,
- and T R Brown
31P-nuclear magnetic resonance evidence of an activated hexose-monophosphate shunt in hyperglycemic rat lenses in vivo.
Diabetes July 1995 44:810-815; doi:10.2337/diabetes.44.7.810
- Abstract
Select this article
- D M Harlan,
- M A Barnett,
- R Abe,
- K Pechhold,
- N B Patterson,
- G S Gray,
- and C H June
Very-low-dose streptozotocin induces diabetes in insulin promoter-mB7-1 transgenic mice.
Diabetes July 1995 44:816-823; doi:10.2337/diabetes.44.7.816
- Abstract
Select this article
- P J Beisswenger,
- Z Makita,
- T J Curphey,
- L L Moore,
- S Jean,
- T Brinck-Johnsen,
- R Bucala,
- and H Vlassara
Formation of immunochemical advanced glycosylation end products precedes and correlates with early manifestations of renal and retinal disease in diabetes.
Diabetes July 1995 44:824-829; doi:10.2337/diabetes.44.7.824
- Abstract
Select this article
- A Salehi,
- G Panagiotidis,
- L A Borg,
- and I Lundquist
The pseudotetrasaccharide acarbose inhibits pancreatic islet glucan-1,4-alpha-glucosidase activity in parallel with a suppressive action on glucose-induced insulin release.
Diabetes July 1995 44:830-836; doi:10.2337/diabetes.44.7.830
- Abstract
Select this article
- A Battezzati,
- I Terruzzi,
- G Perseghin,
- E Bianchi,
- V Di Carlo,
- G Pozza,
- and L Luzi
Defective insulin action on protein and glucose metabolism during chronic hyperinsulinemia in subjects with benign insulinoma.
Diabetes July 1995 44:837-844; doi:10.2337/diabetes.44.7.837
- Abstract
Select this article
- G Toffolo,
- F De Grandi,
- and C Cobelli
Estimation of beta-cell sensitivity from intravenous glucose tolerance test C-peptide data. Knowledge of the kinetics avoids errors in modeling the secretion.
Diabetes July 1995 44:845-854; doi:10.2337/diabetes.44.7.845
- Abstract
Select this article
- H Masuzaki,
- Y Ogawa,
- N Isse,
- N Satoh,
- T Okazaki,
- M Shigemoto,
- K Mori,
- N Tamura,
- K Hosoda,
- and Y Yoshimasa
Human obese gene expression. Adipocyte-specific expression and regional differences in the adipose tissue.
Diabetes July 1995 44:855-858; doi:10.2337/diabetes.44.7.855
- Abstract
- P Gladstone and
- G T Nepom
The prevention of IDDM. Injecting insulin into the cytokine network.
Diabetes July 1995 44:859-862

Current Issue

February 2012, 61 (2)

Print ISSN: 0012-1797
Online ISSN: 1939-327X

Diabetes

Microvascular function in human diabetes. A physiological perspective.

An (A-C)n dinucleotide repeat polymorphic marker at the 5' end of the aldose reductase gene is associated with early-onset diabetic retinopathy in NIDDM patients.

Apoptotic cell death triggered by nitric oxide in pancreatic beta-cells.

Unchanged incidence of diabetic nephropathy in IDDM patients.

Expression of intercellular adhesion molecule 1 on pancreatic beta-cells accelerates beta-cell destruction by cytotoxic T-cells in murine autoimmune diabetes.

Cloning and expression of cytokine-inducible nitric oxide synthase cDNA from rat islets of Langerhans.

Glomerular mesangial cell altered contractility in high glucose is Ca2+ independent.

Glucagon-like peptide I increases cytoplasmic calcium in insulin-secreting beta TC3-cells by enhancement of intracellular calcium mobilization.

Bone loss and bone turnover in diabetes.

On the mechanisms of blunted nocturnal decline in arterial blood pressure in NIDDM patients with diabetic nephropathy.

Diabetic ketoacidosis in obese African-Americans.

The Wisconsin Epidemiologic Study of Diabetic Retinopathy. XVI. The relationship of C-peptide to the incidence and progression of diabetic retinopathy.

Glucose-induced insulin receptor tyrosine phosphorylation in insulin-secreting beta-cells.

31P-nuclear magnetic resonance evidence of an activated hexose-monophosphate shunt in hyperglycemic rat lenses in vivo.

Very-low-dose streptozotocin induces diabetes in insulin promoter-mB7-1 transgenic mice.

Formation of immunochemical advanced glycosylation end products precedes and correlates with early manifestations of renal and retinal disease in diabetes.

The pseudotetrasaccharide acarbose inhibits pancreatic islet glucan-1,4-alpha-glucosidase activity in parallel with a suppressive action on glucose-induced insulin release.

Defective insulin action on protein and glucose metabolism during chronic hyperinsulinemia in subjects with benign insulinoma.

Estimation of beta-cell sensitivity from intravenous glucose tolerance test C-peptide data. Knowledge of the kinetics avoids errors in modeling the secretion.

Human obese gene expression. Adipocyte-specific expression and regional differences in the adipose tissue.

The prevention of IDDM. Injecting insulin into the cytokine network.

This Issue

Current Issue